Oncology · Phase I

Top sponsors

• Chinese Academy of 70 programs
• First People's Hospital 62 programs
• Takeda 49 programs
• United Therapeutics Europe 41 programs
• BEONE MEDICINES AUS 40 programs
• Regeneron UK 34 programs
• Anaxis Pharma 31 programs
• Chongqing Precision Biotech 27 programs
• Janssen-Cilag International N.V 27 programs
• Novartis India 27 programs
• Boehringer Ingelheim 24 programs
• BRIGHT MINDS BIOSCIENCES 23 programs

1. CT-P51 1.1

   Celltrion Healthcare Australia Pty Ltd

   Completely Resected Stage IIB, IIC, and III Melanoma

   phase 1 · other · active

   1 trial →

2. CT053PTSA

   Sunshine Guojian Pharmaceutical (Shanghai) Co.,

   Advanced Solid Tumors

   phase 1 · small molecule · completed

   1 trial →

3. CT053PTSA

   Sunshine Guojian Pharmaceutical (Shanghai) Co.,

   Acute Myeloid Leukemia (AML)

   phase 1 · small molecule · terminated

   1 trial →

4. CTA101

   The First People's Hospital of Lianyungang

   Diffuse Large B-cell Lymphoma

   phase 1 · mab · active

   1 trial →

5. CTIM-76

   Context Therapeutics

   Platinum-resistant Ovarian Cancer

   phase 1 · small molecule · active

   1 trial →

6. CTM-N2D

   CytoMed Therapeutics Ltd

   Colorectal Cancer

   phase 1 · mab · active

   1 trial →

7. CTM-N2D-102

   CytoMed Therapeutics Ltd

   Cancer

   phase 1 · mab · active

   1 trial →

8. CTNO155X2101

   Novartis Pharmaceuticals

   Advanced solid tumors

   phase 1 · other · active

   1 trial →

9. CTX-10726

   Compass Therapeutics

   Gastroesophageal Cancer (GC)

   phase 1 · small molecule · active

   1 trial →

10. CTX-471

    Compass Therapeutics

    Locally Advanced Solid Tumor

    phase 1 · small molecule · completed

    1 trial →

11. CTX-8371

    Compass Therapeutics

    Non Small Cell Lung Cancer

    phase 1 · small molecule · active

    1 trial →

12. CTX130

    S.A.

    Renal Cell Carcinoma

    phase 1 · mab · terminated

    1 trial →

13. CTX130

    S.A.

    T Cell Lymphoma

    phase 1 · mab · terminated

    1 trial →

14. CUE-101

    Cue Biopharma

    Head and Neck Cancer

    phase 1 · small molecule · completed

    1 trial →

15. CUE-102

    Cue Biopharma

    Colorectal Cancer

    phase 1 · small molecule · completed

    1 trial →

16. CV-HNLC-001

    CureVac AG

    metastatic squamous non-small cell lung cancer

    phase 1 · other · active

    1 trial →

17. CVA

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 1 · small molecule · active

    1 trial →

18. CVAY736J12101

    Novartis Pharmaceuticals

    Relapsed/refractory Non Hodgkin Lymphoma

    phase 1 · other · active

    1 trial →

19. CX-188

    CytomX Therapeutics

    Solid Tumor, Adult

    phase 1 · small molecule · terminated

    1 trial →

20. CX-2051

    CytomX Therapeutics

    Solid Tumor, Adult

    phase 1 · small molecule · active

    1 trial →

21. CX-801

    CytomX Therapeutics

    Solid Tumor, Adult

    phase 1 · small molecule · active

    1 trial →

22. CX-904

    CytomX Therapeutics

    Solid Tumors

    phase 1 · small molecule · terminated

    1 trial →

23. CXD101

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 · small molecule · completed

    1 trial →

24. CY-219 CAR-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory B-cell Lymphoma

    phase 1 · small molecule · active

    1 trial →

25. Cabiralizumab

    Prime Medicine

    Advanced Solid Tumors

    phase 1 · mab · completed

    1 trial →

26. Camidanlumab tesirine

    ADC Therapeutics SA

    Hodgkin Lymphoma

    phase 1 · small molecule · completed

    1 trial →

27. Camrelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Cancer

    phase 1 · small molecule · active

    1 trial →

28. Camsirubicin

    Monopar Therapeutics

    Advanced Soft-tissue Sarcoma

    phase 1 · small molecule · terminated

    1 trial →

29. Canagliflozin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    phase 1 · small molecule · active

    1 trial →

30. Carfilzomib

    Lxo Ireland Designated Activity Company

    Acute Lymphoblastic Leukemia (ALL)

    phase 1 · small molecule · completed

    1 trial →

31. Carmustine

    ADC Therapeutics SA

    Recurrent Diffuse Large B-Cell Lymphoma

    phase 1 · small molecule · terminated

    1 trial →

32. Cemiplimab

    Regeneron UK Limited

    Epithelial Ovarian Cancer

    phase 1 · small molecule · active

    1 trial →

33. Cemiplimab

    Regeneron UK Limited

    Lung Cancer

    phase 1 · small molecule · active

    1 trial →

34. Cemiplimab

    Regeneron UK Limited

    Anaplastic Thyroid Cancer

    phase 1 · mab · active

    1 trial →

35. Cemiplimab

    Regeneron UK Limited

    Locally Advanced Head and Neck Squamous Cell Carcinoma

    phase 1 · small molecule · active

    1 trial →

36. Cemiplimab

    Regeneron UK Limited

    Advanced Cancer

    phase 1 · small molecule · completed

    1 trial →

37. Cemiplimab

    Regeneron UK Limited

    Hormone Receptor-positive Breast Cancer

    phase 1 · small molecule · completed

    1 trial →

38. Cemiplimab-Rwlc

    Regeneron UK Limited

    Merkel Cell Carcinoma

    phase 1 · small molecule · active

    1 trial →

39. Chemophase

    HALOZYME THERAPEUTICS, INC.

    Superficial Bladder Cancer

    phase 1 · small molecule · completed

    1 trial →

40. Chimeric antigen receptor T cell

    The First People's Hospital of Lianyungang

    Pancreatic Cancer

    phase 1 · small molecule · active

    1 trial →

41. Ciforadenant

    Corvus Pharmaceuticals

    Renal Cell Cancer

    phase 1 · small molecule · completed

    1 trial →

42. Cisplatin

    Regeneron UK Limited

    Head and Neck Cancer

    phase 1 · small molecule · active

    1 trial →

43. Cisplatin

    United Therapeutics Europe Ltd

    Advanced Cholangiocarcinoma

    phase 1 · small molecule · terminated

    1 trial →

44. Cisplatin

    AstraZeneca

    Inoperable Locally Advanced or Metastatic Biliary Tract Cancer

    phase 1 · small molecule · terminated

    1 trial →

45. Cisplatin

    BioMarin Pharmaceutical Australia Pty Ltd

    Solid Tumors

    phase 1 · small molecule · terminated

    1 trial →

46. Click-cleavable imaging in HER2-positive cancers (CleavHER trial).

    Disc Medicine

    HER2-positive tumors

    phase 1 · other · active

    1 trial →

47. Clifutinib Besylate

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia

    phase 1 · small molecule · completed

    1 trial →

48. Clifutinib with fed state

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia in Children

    phase 1 · small molecule · completed

    1 trial →

Frequently asked questions